Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06685042
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:37.226139+00:00
Published At
2025-04-11T00:00:00+00:00
Record Updated At
2025-04-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lupus Erythematosus, Systemic", "System; Sclerosis", "ANCA Associated Vasculitis", "Dermatomyositis", "Polymyositis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-11"
protocolSection.identificationModule.nctId
"NCT06685042"
protocolSection.identificationModule.officialTitle
"Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lupus Erythematosus, Systemic (protocolSection.conditionsModule.conditions)
  • System; Sclerosis (protocolSection.conditionsModule.conditions)
  • ANCA Associated Vasculitis (protocolSection.conditionsModule.conditions)
  • Dermatomyositis (protocolSection.conditionsModule.conditions)
  • Polymyositis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.